Stock listing

HKEX:2617 TransThera Sciences (Nanjing). Inc. (藥捷安康) 股價

Home listing (HKEX) of TransThera Sciences (Nanjing). Inc.

Follow TransThera Sciences (Nanjing). Inc. into a list and get an email when it puts out news.

Share price · HKEX:2617

$9.34 HKD -0.27 (-2.9%)

Close on Oct 14, 2026

Ticker: HKEX:2617
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: HKEX
Currency: HKD

What changed lately

Latest news release · Oct 5, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

Latest news

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

Oct 5, 2026

Interim report 2026

Sep 21, 2026

Voluntary announcement first patient dosed in phase II clinical trial of tinengotinib in combination with novel hormonal therapy for pretreated and progressed metastatic castration-resistant prostate cancer in China

Sep 18, 2026

Voluntary announcement inclusion of yochanra (tinengotinib) in the CSCO guidelines for the diagnosis and treatment of biliary tract cancers (2026)

Sep 18, 2026

New drug application for Tinengotinib tablets accepted by the national medical products administration

Dec 18, 2025

TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet

Dec 4, 2025

Inclusion of Tinengotinib tablets in the list of products for priority review by the national medical products administration

Dec 3, 2025

All TransThera Sciences (Nanjing). Inc. news

TransThera Sciences (Nanjing). Inc. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 7 in the last 12 months · 7 in all · newest Oct 5, 2026 · oldest 2025

Where TransThera Sciences (Nanjing). Inc. is listed

Listing	Exchange	Country	Currency
HKEX:2617 藥捷安康 · Home listing · This page	HKEX	Hong Kong	HKD
Frankfurt:J8J	Frankfurt	Germany	EUR

Log in to ask 6ix AI your own questions about TransThera Sciences (Nanjing). Inc.